Details of the Drug Therapeutic Target (DTT)

General Information of Drug Therapeutic Target (DTT) (ID: TTP03CE)

DTT Name	Hepatitis C virus microRNA miR-122 (HCV MIR122)
Gene Name	HCV MIR122
DTT Type	Clinical trial target	[1]
BioChemical Class	Non-coding RNA target
UniProt ID	NOUNIPROTAC
TTD ID	T66093

Molecular Interaction Atlas (MIA) of This DTT

Molecular Interaction Atlas (MIA)

Jump to Detail Molecular Interaction Atlas of This DTT

2 Clinical Trial Drug(s) Targeting This DTT

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
Miravirsen	DMWJMFZ	Hepatitis C virus infection	1E51.1	Phase 2	[2]
RG-101	DM2UGT7	Hepatitis C virus infection	1E51.1	Phase 2	[1]
------------------------------------------------------------------------------------

References

1	Company report (Isis Pharmaceuticals)
2	Miravirsen (SPC3649) can inhibit the biogenesis of miR-122.Nucleic Acids Res.2014 Jan;42(1):609-21.